Geode Capital Management’s COSCIENS Biopharma CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-915
Closed -$18K – 5046
2022
Q2
$18K Hold
915
– – ﹤0.01% 4941
2022
Q1
$33K Hold
915
– – ﹤0.01% 4888
2021
Q4
$32K Hold
915
– – ﹤0.01% 4916
2021
Q3
$68K Buy
915
+384
+72% +$27.3K ﹤0.01% 4747
2021
Q2
$46K Hold
531
– – ﹤0.01% 4667
2021
Q1
$60K Buy
531
+292
+122% +$32.4K ﹤0.01% 4384
2020
Q4
$10K Hold
239
– – ﹤0.01% 4266
2020
Q3
$8K Hold
239
– – ﹤0.01% 4152
2020
Q2
$19K Hold
239
– – ﹤0.01% 4072
2020
Q1
$12K Hold
239
– – ﹤0.01% 4071
2019
Q4
$21K Hold
239
– – ﹤0.01% 4154
2019
Q3
$24K Hold
239
– – ﹤0.01% 4131
2019
Q2
$70K Buy
+239
New +$84.2K ﹤0.01% 4021
2015
Q4
– Sell
-1
Closed -$1K – 4153
2015
Q3
$1K Hold
1
– – ﹤0.01% 4124
2015
Q2
$3K Hold
1
– – ﹤0.01% 3957
2015
Q1
$6K Hold
1
– – ﹤0.01% 3947
2014
Q4
$6K Hold
1
– – ﹤0.01% 3973
2014
Q3
$15K Buy
+1
New +$12.8K ﹤0.01% 3908

Other funds holding CSCI

Geode Capital Management's CSCI Position: Q3 2022 in Review

Geode Capital Management sold out of COSCIENS Biopharma (CSCI) in Q3 2022, closing a stake of 915 shares — an estimated $18K sold.

Geode Capital Management first reported a position in CSCI in Q3 2014 and held it in 18 quarters. The position peaked at $70K in Q2 2019. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

  • Geode Capital Management reported no remaining COSCIENS Biopharma position as of Q3 2022 after selling out during the quarter.
  • Geode Capital Management sold 915 COSCIENS Biopharma shares in Q3 2022, an estimated $18K.
  • Geode Capital Management first reported a position in COSCIENS Biopharma in Q3 2014 and held it in 18 quarters.
  • Geode Capital Management's COSCIENS Biopharma position peaked at $70K in Q2 2019.
  • 12 funds tracked by Wall St. Rank held COSCIENS Biopharma as of Q3 2022.

Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.